CCND1 and neoplasm: This suggests that the targeted genes or oncogenic pathways act synergistically and are advantageous for the tumor: for example, CCND1 (11q13.3) targeting the G1/S checkpoint, and MDM2 (12q15) targeting the p53 pathway.